LungBlog
The Lung Cancer Foundation's
LungBlog
An up-to-the-minute dose of health and hope for lung cancer
Erbitux Application For Type Of Lung Cancer Pulled
January 26th, 2009
ImClone Systems and Bristol-Myers Squibb Co. (BMY) withdrew their pending application for Erbitux to treat a type of lung cancer Friday after the Food and Drug Administration raised questions about potential differences between the product made in the U.S. and Europe.
Posted in Research by Debi
Post a comment | No Comments posted yet | Trackback
Four More Reasons To Drink Red Wine
January 26th, 2009
It May Lower Lung Cancer Risk. Moderate consumption of red wine may decrease the risk of lung cancer in men, researchers reported in the October issue of Cancer Epidemiology, Biomarkers and Prevention. Analyzing data collected from the California Men�s Health Study, they found that each glass of red wine consumed a month correlated with a 2 percent lower lung cancer risk. Men who drank one or two glasses of red wine a day saw a 60 percent reduced lung cancer risk. There were no similar benefits for white wine, beer or liquor drinkers, though, and smokers who drank red wine still, of course, had a higher lung-cancer risk than non-smokers.
Posted in Research, Prevention by Debi
Post a comment | No Comments posted yet | Trackback
Blood test clue for lung cancer treatment
January 26th, 2009
Cancer Research UK-funded scientists have identified a new molecular marker in blood which could indicate how patients with a type of lung cancer will respond to treatment, according to research published in Clinical Cancer Research.
Researchers at the Physiological Laboratory, University of Liverpool and cancer specialists at Clatterbridge Centre for Oncology found that a molecule called SCG3 mRNA** in the bloodstream has a high association with a type of lung cancer called neuroendocrine small cell lung cancer (SCLC).
The marker could be developed for use in blood tests to see how well patients might respond to treatment for this type of lung cancer. The discovery may in future help doctors make more informed decisions about therapy or recommend that patients take part in trials to try new treatments that might be more effective for them.
Posted in Research, Early Detection, Small-Cell by Debi
Post a comment | No Comments posted yet | Trackback
Researchers identify another potential biomarker
January 26th, 2009
A recently discovered class of molecules called microRNA regulate the gene expression changes in airway cells that occur with smoking and lung cancer researchers say.
In a study that appears in the on-line early edition of the journal Proceedings of the National Academy of Sciences, researchers from Boston University School of Medicine (BUSM) have demonstrated that these molecules could lead to a new, relatively non-invasive biomarker for smoking-related lung diseases.
Posted in Research by Debi
Post a comment | No Comments posted yet | Trackback
Racial gap decreases when patients given same treatment
January 26th, 2009
Disparities in survival among black patients diagnosed with early-stage lung cancer are not seen when patients undergo appropriate treatment, a new study shows.
Earlier studies have shown that black patients with early-stage lung cancer have lower five-year survival rates than white patients, and this difference in outcome has been attributed to lower rates of surgery among black patients. Why that is the case remains unknown, and theories abound trying to explain it.
Posted in Research, Education by Debi
Post a comment | No Comments posted yet | Trackback
Varian Medical Systems and BrainLAB to Showcase Novalis Tx(TM) Platform for Non-Invasive Image-Guided Radiosurgery
January 26th, 2009
A new non-invasive surgical device for eradicating inoperable lung cancer and other conditions is being showcased this week at the 45th Annual Society of Thoracic Surgeons (STS) Meeting in San Francisco. The Novalis Tx(TM) platform from Varian Medical Systems and BrainLAB enables doctors to perform image-guided radiosurgery on tumors of the lung, as well as of the brain, spine, liver, and prostate, without making a single incision.
Posted in Research, Treatment by Debi
Post a comment | No Comments posted yet | Trackback
Cancer rates temper good heart news
January 25th, 2009
Erie County is winning the fight against heart disease and stroke.
But cancer, particularly lung cancer, is proving to be a difficult opponent.
The 2009 Erie County Health Profile shows that the county�s death rates for heart disease and stroke both declined significantly, from 291.5 deaths per 100,000 people in 1996-98 to 229.2 deaths in 2004-06.
The cancer rate increased slightly during that time, from 203.3 deaths to 204.7. The rate for lung cancer increased from 54.8 to 62.7.
Posted in Research by Debi
Post a comment | No Comments posted yet | Trackback
Panel to answer questions about lung cancer
January 25th, 2009
St. Mary Mercy Hospital will offer a presentation called �Let�s Talk About Lung Cancer� at 6:30 p.m. Thursday, Jan. 29, in the St. Mary Mercy Hospital Auditorium.
Posted in Research by Debi
Post a comment | No Comments posted yet | Trackback
Lilly, Bristol withdraw FDA Erbitux lung cancer application
January 23rd, 2009
ImClone Systems, which was recently acquired by Eli Lilly & Co., and Bristol-Myers Squibb Co.said Friday they decided to withdraw a Food and Drug Administration application to market cancer drug Erbitux for a type of advanced lung cancer. The drug makers said they will eventually resubmit the application. Erbitux is currently approved for colorectal cancer and head and neck cancer
ImClone Systems, which was recently acquired by Eli Lilly & Co., and Bristol-Myers Squibb Co.said Friday they decided to withdraw a Food and Drug Administration application to market cancer drug Erbitux for a type of advanced . The drug makers said they will eventually resubmit the application. Erbitux is currently approved for colorectal cancer and head and neck cancer
Posted in Research by Debi
Post a comment | No Comments posted yet | Trackback
Merle Haggard Doing �Better Every Day� After Lung Cancer Surgery
January 22nd, 2009
Just two months after undergoing lung cancer surgery, Merle Haggard says he�s back in business.
�I�m doing real well � a little better every day,� the country legend tells PEOPLE. �I have a little bicycle in the back room I�m starting to exercise on and I�m going into the studio to see how my voice sounds.�
Haggard, 71, had surgery in November to remove a lemon-sized tumor. �Most of the reports were like, �He�s got six months to live!� There was never any indication of that,� he says.
Posted in Research, Other News by Debi
Post a comment | No Comments posted yet | Trackback
� Previous Entries
� Copyright 2006 The Bonnie J. Addario A Breath Away From The Cure Foundation. All Rights Reserved.
601 4th Street Suite 215 | San Francisco, CA 94107 | 415.357.1278 ph | info@abreathawayfromthecure.org
Votes:4
Comments: 0